STOCK TITAN

Vanguard discloses 5.26% Absci Corp (ABSI) ownership stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

The Vanguard Group has filed a Schedule 13G reporting beneficial ownership of 7,910,205 shares of Absci Corp common stock, representing 5.26% of the class as of 12/31/2025.

Vanguard reports shared voting power over 996,166 shares and shared dispositive power over 7,910,205 shares, with no sole voting or dispositive power. The filing states these securities are held in the ordinary course of business and not for changing or influencing control of Absci. Vanguard notes an internal realignment effective 01/12/2026, after which certain subsidiaries may report beneficial ownership separately while continuing the same investment strategies.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:01/30/2026

FAQ

What stake in Absci Corp (ABSI) did The Vanguard Group report?

The Vanguard Group reported beneficial ownership of 7,910,205 Absci Corp common shares, representing 5.26% of the outstanding class as of 12/31/2025. This makes Vanguard a significant institutional holder under SEC disclosure rules.

How much voting and dispositive power does Vanguard have over Absci (ABSI) shares?

Vanguard reports shared voting power over 996,166 Absci shares and shared dispositive power over 7,910,205 shares, with no sole voting or dispositive power. This means decisions are made jointly, typically for client accounts, rather than solely by Vanguard.

Is Vanguard’s Absci (ABSI) position passive or intended to influence control?

Vanguard certifies the Absci position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of the company. This aligns with a Schedule 13G passive investment filing.

Who ultimately benefits from the Absci (ABSI) shares reported by Vanguard?

Vanguard states its clients, including registered investment companies and other managed accounts, have the right to receive dividends or sale proceeds from the Absci shares. No single other person has an interest in more than 5% of the class through these holdings.

What internal changes at The Vanguard Group are mentioned in the Absci (ABSI) filing?

The filing notes that on 01/12/2026, Vanguard underwent an internal realignment and no longer performs portfolio management or proxy voting. Certain subsidiaries or business divisions may report beneficial ownership separately while pursuing the same investment strategies.

What does a 5% ownership disclosure like this mean for Absci (ABSI) investors?

A 5% disclosure signals that a large institution, here The Vanguard Group, holds a sizable Absci stake. It reflects current ownership and voting arrangements but, in this case, is characterized as a passive, ordinary-course investment rather than an attempt to influence corporate control.
Absci Corp

NASDAQ:ABSI

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

455.63M
136.23M
9.25%
60.02%
21.14%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER